National Depreciation And Amortization vs Interest Income Analysis

NHI Stock

USD 62.78 0.11 0.17%

National Health financial indicator trend analysis is infinitely more than just investigating National Health Investors recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether National Health Investors is a good investment. Please check the relationship between National Health Depreciation And Amortization and its Interest Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Depreciation And Amortization vs Interest Income

Depreciation And Amortization vs Interest Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of National Health Investors Depreciation And Amortization account and Interest Income. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between National Health's Depreciation And Amortization and Interest Income is -0.65. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Interest Income in the same time period over historical financial statements of National Health Investors, assuming nothing else is changed. The correlation between historical values of National Health's Depreciation And Amortization and Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of National Health Investors are associated (or correlated) with its Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Income has no effect on the direction of Depreciation And Amortization i.e., National Health's Depreciation And Amortization and Interest Income go up and down completely randomly.

Correlation Coefficient

-0.65

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Most indicators from National Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into National Health Investors current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

As of now, National Health's Selling General Administrative is increasing as compared to previous years. The National Health's current Enterprise Value is estimated to increase to about 3.7 B, while Discontinued Operations is projected to decrease to under 16.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	287.1M	268.4M	308.3M	169.0M
Total Revenue	298.7M	278.2M	319.8M	170.8M

Gross Profit Total Revenue

National Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Currrent Assets Other	Other Assets	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Non Current Assets Total	Net Receivables	Total Current Assets	Other Current Liab	Total Current Liabilities	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock	Short Term Debt	Other Liab	Long Term Debt
Total Assets		0.99	0.99	0.69	0.93	-0.06	0.2	0.45	0.92	0.93	0.52	0.99	0.58	1.0	0.9	0.88	-0.37	0.9	0.7	0.25	0.21	0.95	0.95	0.36	-0.19	0.99
Short Long Term Debt Total	0.99		0.96	0.65	0.94	-0.06	0.19	0.45	0.85	0.94	0.51	1.0	0.48	0.98	0.9	0.86	-0.38	0.92	0.69	0.22	0.17	0.92	0.92	0.38	-0.22	1.0
Total Stockholder Equity	0.99	0.96		0.72	0.9	-0.06	0.22	0.43	0.95	0.91	0.53	0.96	0.66	0.99	0.89	0.87	-0.34	0.87	0.69	0.27	0.25	0.95	0.94	0.32	-0.16	0.95
Property Plant And Equipment Net	0.69	0.65	0.72		0.67	0.01	0.44	0.16	0.7	0.66	0.35	0.65	0.63	0.72	0.57	0.52	-0.14	0.5	0.5	0.1	-0.04	0.61	0.62	0.1	0.14	0.64
Net Debt	0.93	0.94	0.9	0.67		0.17	0.13	0.39	0.82	1.0	0.32	0.94	0.35	0.92	0.91	0.87	-0.37	0.9	0.84	0.33	0.19	0.89	0.89	0.36	-0.33	0.96
Retained Earnings	-0.06	-0.06	-0.06	0.01	0.17		-0.28	-0.18	0.04	0.18	-0.87	-0.06	-0.1	-0.07	0.14	0.11	0.09	0.15	0.6	0.36	0.17	0.19	0.2	-0.11	-0.46	-0.03
Non Currrent Assets Other	0.2	0.19	0.22	0.44	0.13	-0.28		-0.34	0.14	0.12	0.34	0.18	0.29	0.28	-0.11	-0.2	0.39	-0.15	-0.15	-0.58	-0.59	0.06	0.06	-0.4	0.35	0.16
Other Assets	0.45	0.45	0.43	0.16	0.39	-0.18	-0.34		0.36	0.41	0.38	0.45	0.08	0.4	0.5	0.57	-0.51	0.46	0.21	0.73	0.76	0.39	0.39	0.52	-0.13	0.45
Common Stock Shares Outstanding	0.92	0.85	0.95	0.7	0.82	0.04	0.14	0.36		0.83	0.43	0.86	0.77	0.91	0.86	0.85	-0.38	0.81	0.72	0.35	0.34	0.92	0.92	0.34	-0.22	0.85
Non Current Liabilities Total	0.93	0.94	0.91	0.66	1.0	0.18	0.12	0.41	0.83		0.32	0.94	0.35	0.92	0.91	0.87	-0.38	0.91	0.85	0.36	0.22	0.89	0.9	0.37	-0.34	0.96
Other Stockholder Equity	0.52	0.51	0.53	0.35	0.32	-0.87	0.34	0.38	0.43	0.32		0.51	0.35	0.53	0.32	0.34	-0.26	0.29	-0.14	-0.14	-0.02	0.28	0.27	0.26	0.29	0.48
Total Liab	0.99	1.0	0.96	0.65	0.94	-0.06	0.18	0.45	0.86	0.94	0.51		0.49	0.98	0.9	0.87	-0.39	0.92	0.69	0.22	0.18	0.93	0.93	0.39	-0.22	1.0
Property Plant And Equipment Gross	0.58	0.48	0.66	0.63	0.35	-0.1	0.29	0.08	0.77	0.35	0.35	0.49		0.61	0.41	0.41	-0.13	0.39	0.28	0.08	0.2	0.61	0.61	0.06	0.24	0.45
Non Current Assets Total	1.0	0.98	0.99	0.72	0.92	-0.07	0.28	0.4	0.91	0.92	0.53	0.98	0.61		0.86	0.83	-0.34	0.87	0.68	0.21	0.17	0.93	0.93	0.33	-0.13	0.97
Net Receivables	0.9	0.9	0.89	0.57	0.91	0.14	-0.11	0.5	0.86	0.91	0.32	0.9	0.41	0.86		0.99	-0.4	0.96	0.8	0.44	0.35	0.9	0.91	0.4	-0.47	0.91
Total Current Assets	0.88	0.86	0.87	0.52	0.87	0.11	-0.2	0.57	0.85	0.87	0.34	0.87	0.41	0.83	0.99		-0.45	0.93	0.77	0.51	0.44	0.89	0.89	0.44	-0.48	0.88
Other Current Liab	-0.37	-0.38	-0.34	-0.14	-0.37	0.09	0.39	-0.51	-0.38	-0.38	-0.26	-0.39	-0.13	-0.34	-0.4	-0.45		-0.45	-0.36	-0.62	-0.61	-0.37	-0.37	-0.99	0.31	-0.39
Total Current Liabilities	0.9	0.92	0.87	0.5	0.9	0.15	-0.15	0.46	0.81	0.91	0.29	0.92	0.39	0.87	0.96	0.93	-0.45		0.79	0.38	0.32	0.91	0.91	0.45	-0.4	0.93
Accounts Payable	0.7	0.69	0.69	0.5	0.84	0.6	-0.15	0.21	0.72	0.85	-0.14	0.69	0.28	0.68	0.8	0.77	-0.36	0.79		0.51	0.33	0.81	0.82	0.33	-0.55	0.72
Cash	0.25	0.22	0.27	0.1	0.33	0.36	-0.58	0.73	0.35	0.36	-0.14	0.22	0.08	0.21	0.44	0.51	-0.62	0.38	0.51		0.94	0.35	0.36	0.59	-0.39	0.25
Cash And Short Term Investments	0.21	0.17	0.25	-0.04	0.19	0.17	-0.59	0.76	0.34	0.22	-0.02	0.18	0.2	0.17	0.35	0.44	-0.61	0.32	0.33	0.94		0.31	0.31	0.58	-0.27	0.18
Common Stock Total Equity	0.95	0.92	0.95	0.61	0.89	0.19	0.06	0.39	0.92	0.89	0.28	0.93	0.61	0.93	0.9	0.89	-0.37	0.91	0.81	0.35	0.31		1.0	0.35	-0.33	0.93
Common Stock	0.95	0.92	0.94	0.62	0.89	0.2	0.06	0.39	0.92	0.9	0.27	0.93	0.61	0.93	0.91	0.89	-0.37	0.91	0.82	0.36	0.31	1.0		0.35	-0.34	0.93
Short Term Debt	0.36	0.38	0.32	0.1	0.36	-0.11	-0.4	0.52	0.34	0.37	0.26	0.39	0.06	0.33	0.4	0.44	-0.99	0.45	0.33	0.59	0.58	0.35	0.35		-0.34	0.39
Other Liab	-0.19	-0.22	-0.16	0.14	-0.33	-0.46	0.35	-0.13	-0.22	-0.34	0.29	-0.22	0.24	-0.13	-0.47	-0.48	0.31	-0.4	-0.55	-0.39	-0.27	-0.33	-0.34	-0.34		-0.26
Long Term Debt	0.99	1.0	0.95	0.64	0.96	-0.03	0.16	0.45	0.85	0.96	0.48	1.0	0.45	0.97	0.91	0.88	-0.39	0.93	0.72	0.25	0.18	0.93	0.93	0.39	-0.26

Click cells to compare fundamentals

National Health Account Relationship Matchups

National Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.0B	3.1B	2.8B	2.5B	2.5B	1.3B
Short Long Term Debt Total	1.5B	1.5B	1.3B	1.1B	1.1B	586.0M
Total Stockholder Equity	1.5B	1.5B	1.5B	1.3B	1.3B	729.6M
Net Debt	1.4B	1.5B	1.2B	1.1B	1.1B	1.2B
Retained Earnings	(5.3M)	(22.0M)	(84.6M)	(329.6M)	2.5B	2.6B
Non Currrent Assets Other	(308K)	6.8M	7.5M	965K	8.4M	8.0M
Other Assets	304.3M	2.8B	2.5B	45.5M	52.4M	49.7M
Common Stock Shares Outstanding	43.7M	44.7M	45.7M	44.8M	43.4M	32.0M
Liabilities And Stockholders Equity	3.0B	3.1B	2.8B	2.5B	2.5B	1.3B
Non Current Liabilities Total	1.5B	1.5B	1.3B	1.1B	1.1B	1.2B
Other Stockholder Equity	1.5B	1.5B	1.6B	1.6B	(1.2B)	(1.2B)
Total Liab	1.5B	1.6B	1.3B	1.2B	1.2B	610.1M
Non Current Assets Total	2.6B	2.7B	2.3B	2.1B	2.1B	1.2B
Net Receivables	429.4M	390.7M	399.4M	315.0M	334.9M	238.8M
Total Current Assets	463.5M	437.1M	505.2M	379.8M	364.5M	257.1M
Other Current Liab	45.6M	(408.6M)	(34.1M)	(376.4M)	(36.4M)	(34.5M)
Total Current Liabilities	92.9M	87.6M	70.2M	70.0M	79.4M	53.2M
Accounts Payable	26.3M	25.2M	23.2M	25.9M	34.3M	36.0M
Cash	5.2M	43.3M	37.4M	19.3M	22.3M	34.0M
Cash And Short Term Investments	5.2M	43.3M	37.4M	19.3M	22.3M	21.2M
Common Stock Total Equity	446K	452K	459K	434K	499.1K	351.3K
Accumulated Other Comprehensive Income	(3.4M)	(7.1M)	(84.6M)	(329.6M)	(350.2M)	(332.7M)
Common Stock	446K	452K	459K	434K	499.1K	355.8K
Short Term Debt	1.2M	458.4M	75.4M	415.4M	75.4M	61.4M
Other Liab	30.4M	23.3M	14.6M	5.1M	4.5M	4.3M
Long Term Debt	1.4B	1.5B	1.2B	1.1B	1.1B	663.6M
Current Deferred Revenue	19.8M	12.6M	5.7M	5.1M	6.0M	4.6M
Other Current Assets	(431.4M)	(431.5M)	(433.6M)	45.5M	(352.3M)	(334.7M)
Net Tangible Assets	1.5B	1.5B	1.5B	1.3B	1.5B	1.2B
Capital Surpluse	1.5B	1.5B	1.6B	1.6B	1.8B	1.2B
Deferred Long Term Liab	10.1M	12.6M	5.7M	5.1M	5.8M	4.6M
Long Term Investments	141.5M	246.1M	292.4M	300.0M	344.9M	187.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:

How To Invest In National

Details

Is National Stock a good investment?

Details

What is National Health's Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Note that the National Health Investors information on this page should be used as a complementary analysis to other National Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for National Stock analysis

When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.

	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Transaction History View history of all your transactions and understand their impact on performance

Is National Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.14)

Dividend Share

3.6

Earnings Share

3.13

Revenue Per Share

7.384

Quarterly Revenue Growth

(0.12)

The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

National Depreciation And Amortization vs Interest Income Analysis

Depreciation And Amortization vs Interest Income

Depreciation And Amortization vs Interest Income Correlation Analysis

Correlation Coefficient

Depreciation And Amortization

Interest Income

National Health fundamental ratios Correlations

National Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

National Health fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for National Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Total Liab	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Net Debt
Long Term Debt	+ 1.0	Total Liab
Common Stock	+ 1.0	Common Stock Total Equity

Short Term Debt	- 0.99	Other Current Liab
Other Stockholder Equity	- 0.87	Retained Earnings
Cash	- 0.62	Other Current Liab
Cash And Short Term Investments	- 0.61	Other Current Liab
Cash And Short Term Investments	- 0.59	Non Currrent Assets Other
Cash	- 0.58	Non Currrent Assets Other